Astellas pioneers use of double-armed robot Mahoro in cell culture R&D
https://bio.nikkeibp.co.jp/atcl/news/p1/23/08/18/11005/ According to Nikkei Biotech, Astellas Pharma Inc. held a
https://bio.nikkeibp.co.jp/atcl/news/p1/23/08/18/11005/ According to Nikkei Biotech, Astellas Pharma Inc. held a
https://fermelanta.com https://bio.nikkeibp.co.jp/atcl/column/16/021500017/080100292/ Firmelanta is a startup from Ishikawa Prefectural University
https://www.nedo.go.jp/news/press/AA5_101678. As part of the Green Innovation Fund Project, NEDO
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/29/10868/ The general-purpose humanoid robot “Mahoro” is one of the
https://bio.nikkeibp.co.jp/atcl/news/p1/23/07/30/10951/ https://carbgem.com/en/ CarbGem and its parent company, NexGen have filed
https://www.nedo.go.jp/news/press/AA5_101674.html Under NEDO’s “Technology Research and Development Project for Discovery
https://bio.nikkeibp.co.jp/atcl/column/16/052000031/072700119/ Morinaga Milk Industry has confirmed that early administration of
https://bio.nikkeibp.co.jp/atcl/news/p1/23/07/18/10912/ On July 18, 2023, Chugai Pharmaceutical held a media
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/29/10868/ The general-purpose humanoid robot “Mahoro” is one of the